NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Devyanshi Dixit: What If the Next IVF Breakthrough Isn’t Better Embryos?
Devyanshi Dixit/LinkedIn
Oct 13, 2026, 14:52

Devyanshi Dixit: What If the Next IVF Breakthrough Isn’t Better Embryos?

Devyanshi Dixit, Program Manager at CLS Event and Publication and Conference Manager at the 12th Global Summit on Gynecology, Fertility and Women’s Health, shared on LinkedIn:

“A high-quality embryo can still fail to implant.

But does that mean the embryo was the problem?

IVF has made remarkable progress in embryo culture, genetic assessment and selection.

Yet implantation remains a biological interaction, not a laboratory result alone.

The endometrium is more than a landing surface.

It is dynamic tissue that:

  • responds to hormonal signals,
  • undergoes cellular differentiation,
  • coordinates molecular processes that help determine whether implantation can proceed.

This raises a more interesting question:

Are we measuring the uterine environment accurately enough to understand why implantation succeeds – or fails?

Endometrial thickness and molecular receptivity tests can provide information, but neither tells the whole story. Receptivity is multifactorial, involving the timing of endometrial development, tissue function and communication between the embryo and maternal environment.

Here is where scientific ambition must meet clinical evidence.

A 2023 systematic review and meta-analysis of 12 studies involving 14,224 patients found no significant improvement in live-birth outcomes with endometrial receptivity analysis compared with standard embryo-transfer protocols.

The UK’s 2026 NICE guideline goes further, recommending against routine endometrial receptivity testing as an IVF add-on.

That does not make endometrial research less important.

It makes the research question more precise.

The opportunity is not simply to develop more tests.

It is to identify which biological mechanisms matter, which patients may benefit from targeted investigation, and which interventions demonstrably improve live-birth outcomes.

The next advance may come from understanding the embryo-endometrium relationship more deeply – not from assuming that either side is solely responsible.

At GFWH 2026, these questions belong in the conversation between reproductive clinicians, embryologists, and researchers.

  • November 23-24, 2026
  • Bangkok, Thailand
  • Hybrid participation
  • Professionals from 50+ countries

For fertility specialists and researchers: what should the next generation of implantation research prioritize – better biomarkers of endometrial function, a deeper understanding of embryo-maternal signaling, or evidence-based interventions for specific patient groups?

I’d welcome your perspective.”

Other articles featuring Devyanshi Dixit on Fertility News.

Devyanshi Dixit embryo Embryology endometrium Fertility Fertility News GFWH GFWH 2026 IVF OBGYN reproductive health Reproductive Medicine Women’s Health
NewsFeed